Staphylococcus aureus subsp. aureus Rosenbach (ATCC® BAA-2094)

Strain Designations: B8-31  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations B8-31
Application
Emerging infectious disease research
Drug discovery
Isolation
Clinical isolate from Australia
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Genotype pvl negative, mecA positive, tsst positive, issea negative
Type Strain no
Antibiotic Resistance Methicillin resistant
Comments MRSA
SCCmec: Type V
PFGE type: WA-MRSA
spa type Ridom: t123
spa type Kreiswirth: A2AKBEKBKB
pvl gene amplification: Negative
Agr Type: I
mecA gene amplification: Positive
tsst gene amplification: Positive
issea gene amplification: Negative

Phenotypic and genotypic information for ATCC MRSA strains, such as SCCmec, PFGE, or spa typing, is provided for informational purposes only. This information was compiled from testing performed by one or more sources, including ATCC, strain depositor, published data, or contracted research.
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Genotype pvl negative, mecA positive, tsst positive, issea negative
Name of Depositor A Derome
Isolation
Clinical isolate from Australia
References

Nimmo GR, Schooneveldt J, et al. Community Acquisition of Gentamicin-Sensitive Methicillin-Resistant Staphylococcus aureus in Southeast Queensland, Autralia. J. Clin. Microbiol. 11: 3926-3931, 2000.

Monecke S, et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 6(4): e17936, 2011. PubMed: 21494333